Dihydro-beta-erythroidine hydrobromide,
29734-68-7,
UNII-NS1U03GC05,
MLS002172468,
NS1U03GC05,
CHEMBL1319741,
(2S,13bS)-2-Methoxy-2,3,5,6,8,9,10,13-octahydro-1H,12H-benzo[i]pyrano[3,4-g]indolizin-12-one hydrobromide,
DH?E,
EU-0100468,
SCHEMBL1320306,
Dihydro-?-erythroidine hydrobromide,
Tox21_500468,
AKOS024457064,
LP00468,
NCGC00093880-01,
NCGC00261153-01,
SMR001254098,
3|A-1,6-Didehydro-14,17-dihydro-3-methoxy-16(15H)-oxaerythrinan-15-one hydrobromide,
3beta-1,6-Didehydro-14,17-dihydro-3-methoxy-16(15H)-oxaerythrinan-15-one hydrobromide,
1H,12H-Pyrano[4',3':3,4]pyrido[2,1-i]indol-12-one, 2,3,5,6,8,9,10,13-octahydro-2-methoxy-, hydrobromide (1:1), (2S,13bS)-,
C16-H21-N-O3.Br-H,
Dihydro-|A-erythroidine hydrobromide,
Dihydro-beta-erythroidine hydrogen bromide,
CID11957537,
beta-ERYTHROIDINE, DIHYDRO-, HYDROBROMIDE,
.beta.-Erythroidine, dihydro-, hydrobromide,
D-149,
.alpha.-Erythroidine, 12,13-didehydro-13,14,?,?-tetrahydro-, hydrobromide,